Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,164 across all filing types
Latest filing 2025-11-07 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Link of Audio Recording of the Earnings Call-Q2 FY26.
Regulatory Filings
2025-11-07 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation - Q2 FY26 Results' and is addressed to stock exchanges and investors. It contains detailed financial performance data for the quarter and half year ended September 30, 2025, including sales, EBITDA, net income, segment performance, business developments, and strategic initiatives. The document includes forward-looking statements, key growth metrics, and operational highlights typical of an investor presentation. It is not a full annual or interim report, nor is it an earnings release with only key highlights. It is a detailed presentation aimed at investors, consistent with the definition of an Investor Presentation (IP). The document length is substantial (15,000 characters), and it contains substantive financial and business information, not just an announcement or certification. Therefore, the appropriate classification is Investor Presentation (IP).
2025-11-06 English
The Company has informed the Exchange about the Investor Presentation on the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2025.
Regulatory Filings
2025-11-06 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated November 6, 2025, announcing the unaudited financial results for the quarter and half year ended September 30, 2025 (Q2 FY26). It includes detailed financial highlights such as sales, EBITDA, PBT, PAT, segment sales, and operational highlights. The document explicitly states it is a "Press Release - Q2 FY26 Results" and contains key financial metrics and commentary from the Managing Director. The presence of quarterly financial data and the nature of the announcement align with an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights. The document is about 11,294 characters, which is substantial and contains actual financial data, not just a brief announcement or a link to a report. Therefore, it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). It is not a full Interim/Quarterly Report (IR) because it lacks comprehensive financial statements and detailed analysis typical of such reports; it is a press release summary. Hence, the correct classification is Earnings Release (ER).
2025-11-06 English
Lupin Q2 FY2026 Results
Regulatory Filings
2025-11-06 English
Outcome of the Board Meeting for Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended September 30, 2025.
Regulatory Filings
2025-11-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.